Skip to main content

Advertisement

Table 1 Eligible KRAS wild-type patients were identified at 38 hospitals in China

From: CMAB009 plus irinotecan versus irinotecan-only as second-line treatment after fluoropyrimidine and oxaliplatin failure in KRAS wild-type metastatic colorectal cancer patients: promising findings from a prospective, open-label, randomized, phase III trial

Participating institutions Principle investigator in each institution No. of patients
Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Yuankai Shi 18
Fudan University Shanghai Cancer Center Jin Li 42
The Affiliated Hospital of Military Medical Sciences Jianming Xu 38
Shanghai General Hospital Liwei Wang 30
Jilin Cancer Hospital Ying Cheng 21
Tumor Hospital of Hebei Province Wei Liu 22
The First Affiliated Hospital of Anhui Medical University Guoping Sun 23
Fujian Provincial Cancer Hospital Yigui Chen 24
Chinese PLA General Hospital Li Bai 20
Zhejiang Cancer Hospital Yiping Zhang 21
Hunan Cancer Hospital Yi Luo 18
Shandong Cancer Hospital Zhehai Wang 18
The First Hospital of China Medical University Yunpeng Liu 18
Tianjin People’s Hospital Qiang Yao 15
Sun Yat-sen University Cancer Center Yuhong Li 14
Chinese PLA Bayi Hospital Shukui Qin 12
The Guangxi Zhuang Autonomous Region Tumor Hospital Xiaohua Hu 12
West China Hospital Feng Bi 11
First Affiliated Hospital of Bengbu Medical College Rongsheng Zheng 10
Fuzhou PLA General Hospital Xuenong Ouyang 10
Peking Union Medical College Hospital Chunmei Bai 10
Tianjin Medical University Cancer Institute & Hospital Yi Ba 16
Jiangsu Cancer Hospital Jifeng Feng 10
General Hospital of Jinan Military Region Baocheng Wang 10
Chongqing General Hospital Min Fu 9
The First Affiliated Hospital of The Third Military Medical University Houjie Liang 7
Tongji Hospital of Tongji Medical College,
Huazhong University of Science and Technology
Shiying Yu 7
Ruijin Hospital, Shanghai Jiaotong University School of Medicine Jun Zhang 6
The Second Xiangya Hospital of Central South University Chunhong Hu 6
No. 3 People Hospital Affiliated to Shanghai Jiaotong University School of Medicine Bin Jiang 5
Chongqing Cancer Hospital Ying Xiang 5
Nanfang Hospital Rongwei Luo 5
The First Affiliated Hospital of Suzhou University Min Tao 4
Affiliated Hospital of Nantong University Guoxin Mao 4
Sichuan Provincial People’s Hospital Honglin Hu 3
Gansu Provincial Cancer Hospital Weihua Zhang 3
Xijing Hospital Wenchao Liu 3
Kunming General Hospital of Chengdu Military Command Hong Chen 2